| Date Filed | Type | Description |
| 07/06/2023 |
4
| Shah Pritesh (Chief Growth Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 367 shares
@ $35.28, valued at
$12.9k
|
|
| 03/07/2023 |
4
| Shah Pritesh (Chief Growth Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 1,570 shares
@ $76.1594, valued at
$119.6k
Sold 2,942 shares
@ $76.1594, valued at
$224.1k
Sold 16,909 shares
@ $76.1594, valued at
$1.3M
|
|
| 03/06/2023 |
4
| Shah Pritesh (Chief Growth Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 937 shares
@ $75.2779, valued at
$70.5k
Granted 3,936 shares
@ $0
Granted 43,246 shares
@ $0 |
|
| 03/02/2023 |
4
| Shah Pritesh (Chief Growth Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 19,055 shares
@ $0
Sold 1,923 shares
@ $76.3624, valued at
$146.8k
Granted 31,691 options to buy
@ $76.97, valued at
$2.4M
|
|
| 01/09/2023 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 387 shares
@ $108, valued at
$41.8k
|
|
| 09/06/2022 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 269 shares
@ $79.037, valued at
$21.3k
|
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2021 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 2,627 shares
@ $130.806, valued at
$343.6k
Sold 3,524 shares
@ $131.09, valued at
$462k
|
|
| 03/09/2021 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 4,550 shares
@ $131.53, valued at
$598.5k
Exercised 13,987 options to buy
@ $7.15, valued at
$100k
|
|
| 03/05/2021 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 2,174 shares
@ $150.78, valued at
$327.8k
Sold 2,658 shares
@ $137.554, valued at
$365.6k
|
|
| 03/04/2021 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 912 shares
@ $152.053, valued at
$138.7k
Granted 10,886 shares
@ $0
Granted 20,004 options to buy
@ $153.09, valued at
$3.1M
|
|
| 03/02/2021 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Exercised 3,086 shares
@ $149.1, valued at
$460.1k
Exercised 3,086 restricted stock units
@ $0 |
|
| 10/30/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Exercised 14,518 options to buy
@ $7.48, valued at
$108.6k
Exercised 5,913 options to buy
@ $14.37, valued at
$85k
Exercised 10,037 options to buy
@ $11.46, valued at
$115k
|
|
| 09/11/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 27,621 shares
@ $85.3926, valued at
$2.4M
Sold 700 shares
@ $86.0736, valued at
$60.3k
|
|
| 09/11/2020 |
4/A
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 4,200 shares
@ $85.0129, valued at
$357.1k
|
|
| 09/03/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 1,968 shares
@ $0
Bought 4,200 shares
@ $85.0129, valued at
$357.1k
Granted 3,779 options to buy
@ $84.68, valued at
$320k
|
|
| 08/03/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Exercised 3,717 shares
@ $76.17, valued at
$283.1k
Exercised 3,717 restricted stock units
@ $0 |
|
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 1,149 shares
@ $62.2, valued at
$71.5k
|
|
| 05/05/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Exercised 2,333 shares
@ $65.8, valued at
$153.5k
Sold 1,184 shares
@ $60.079, valued at
$71.1k
Exercised 2,333 restricted stock units
@ $0 |
|
| 03/10/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 2,906 shares
@ $69.534, valued at
$202.1k
Sold 3,245 shares
@ $64.27, valued at
$208.6k
Exercised 17,500 options to buy
@ $7.48, valued at
$130.9k
|
|
| 03/05/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 21,623 shares
@ $0
Granted 41,690 options to buy
@ $69.37, valued at
$2.9M
|
|
| 03/05/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 1,485 shares
@ $72.97, valued at
$108.4k
|
|
| 03/02/2020 |
4
| Shah Pritesh (Chief Commercial Officer) has filed a Form 4 on NovoCure Ltd|
Txns:
| Exercised 3,086 shares
@ $79.45, valued at
$245.2k
Sold 1,601 shares
@ $72.215, valued at
$115.6k
Exercised 3,086 restricted stock units
@ $0 |
|
|